Will a mAb-Based Immunotherapy Directed Against Cancer Stem Cells Be Feasible?

Frontiers in Immunology - Switzerland
doi 10.3389/fimmu.2017.01509
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA


Related search